Retatrutide (Triple Agonist) — 30mg, batch 2026/4
Tested 2026-04-24
Open original certificate (new tab)
FEATURED
Triple-agonist peptide investigated for body composition research.
For research use only. Not for human consumption.
Shipped as a lyophilized (freeze-dried) powder, ready to be reconstituted. Store as directed after delivery and follow the storage guidance on the batch documentation.
Keep the sealed vial cold and dry after delivery. Reconstitute with bacteriostatic water per your research protocol, then refrigerate at 2–8 °C.
Use aseptic handling and keep the vial closed when not in use. Do not add water or other solvents unless your approved research protocol requires it.
Return to refrigerated storage promptly. Protect from light, avoid repeated freeze-thaw cycles, and discard if cloudy or particulate.
Every batch is independently third-party tested for identity and purity. Published certificates for this product appear below, labelled by size and batch.
Tested 2026-04-24
Open original certificate (new tab)See how this compound differs from related research peptides: molecular identity, vial sizes and batch documentation, side by side.
Retatrutide vs Tirzepatide vs Semaglutide| Compound Name | Retatrutide (Triple Agonist) |
| CAS Number | 2381089-83-2 |
| Formula | C221H342N46O68 |
| Weight | 4731.33 g/mol |
| Sequence | Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-(α-Me-Leu)-Leu-Asp-Lys(γGlu-(AEEA)-C20 diacid)-Lys-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Pro-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors. It is a subject of active metabolic research. Supplied as a lyophilized powder for reconstitution for laboratory research only.
Retatrutide is sold for laboratory research by Honest Science, a Canadian research peptide supplier.
Other compounds in the Metabolic Activation category, for laboratory research only.